Lindå H - Search Results

1

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

Lindå H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C. Lindå H, et al. N Engl J Med. 2009 Sep 10;361(11):1081-7. doi: 10.1056/NEJMoa0810316. N Engl J Med. 2009. PMID: 19741229 Free article.

2

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.

Lindå H, von Heijne A. Lindå H, et al. Front Neurol. 2013 Feb 18;4:11. doi: 10.3389/fneur.2013.00011. eCollection 2013. Front Neurol. 2013. PMID: 23423248 Free PMC article.

3

A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.

Lindå H, von Heijne A. Lindå H, et al. Front Neurol. 2015 Mar 4;6:39. doi: 10.3389/fneur.2015.00039. eCollection 2015. Front Neurol. 2015. PMID: 25788891 Free PMC article.

4

Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.

Haghikia A, Perrech M, Pula B, Ruhrmann S, Potthoff A, Brockmeyer NH, Goelz S, Wiendl H, Lindå H, Ziemssen T, Baranzini SE, Käll TB, Bengel D, Olsson T, Gold R, Chan A. Haghikia A, et al. Among authors: linda h. PLoS One. 2011 Apr 20;6(4):e18506. doi: 10.1371/journal.pone.0018506. PLoS One. 2011. PMID: 21533133 Free PMC article. Clinical Trial.

5

Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons.

Lindå H, Hammarberg H, Piehl F, Khademi M, Olsson T. Lindå H, et al. J Neuroimmunol. 1999 Nov 1;101(1):76-86. doi: 10.1016/s0165-5728(99)00135-6. J Neuroimmunol. 1999. PMID: 10580816

6

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators. Freedman MS, et al. Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5. Neurology. 2011. PMID: 21975206 Clinical Trial.

7

Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy.

Lindå H, Hammarberg H, Cullheim S, Levinovitz A, Khademi M, Olsson T. Lindå H, et al. Exp Neurol. 1998 Apr;150(2):282-95. doi: 10.1006/exnr.1997.6768. Exp Neurol. 1998. PMID: 9527898

8

Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Lindå H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Hammarberg H, et al. Among authors: linda h. J Neurosci. 2000 Jul 15;20(14):5283-91. doi: 10.1523/JNEUROSCI.20-14-05283.2000. J Neurosci. 2000. PMID: 10884312 Free PMC article.

9

Induction of HIF1alpha but not HIF2alpha in motoneurons after ventral funiculus axotomy-implication in neuronal survival strategies.

Sköld MK, Marti HH, Lindholm T, Lindå H, Hammarberg H, Risling M, Cullheim S. Sköld MK, et al. Among authors: linda h. Exp Neurol. 2004 Jul;188(1):20-32. doi: 10.1016/j.expneurol.2004.03.024. Exp Neurol. 2004. PMID: 15191799

10

Expression of GAP-43 mRNA in the adult mammalian spinal cord under normal conditions and after different types of lesions, with special reference to motoneurons.

Lindå H, Piehl F, Dagerlind A, Verge VM, Arvidsson U, Cullheim S, Risling M, Ulfhake B, Hökfelt T. Lindå H, et al. Exp Brain Res. 1992;91(2):284-95. doi: 10.1007/BF00231661. Exp Brain Res. 1992. PMID: 1333987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page